Corvus Pharmaceuticals Inc sell StockNews.com
Start price
28.09.24
/
50%
€4.55
Target price
28.09.25
-
Performance (%)
32.97%
End price
29.09.25
€6.05
Summary
This prediction ended on 29.09.25 with a price of €6.05. The SELL prediction by StockNews_com for Corvus Pharmaceuticals Inc was trending in the completely wrong direction and closed with a performance of 32.97%. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Corvus Pharmaceuticals Inc | 1.014% | 1.014% | 373.663% |
| iShares Core DAX® | 4.852% | -2.747% | 13.097% |
| iShares Nasdaq 100 | 3.999% | -3.330% | 31.335% |
| iShares Nikkei 225® | 4.221% | -2.912% | 44.472% |
| iShares S&P 500 | 3.324% | -2.954% | 24.360% |
Comments by StockNews_com for this prediction
In the thread Corvus Pharmaceuticals Inc diskutieren
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for CRVS provided by MarketBeat
In the thread Trading Corvus Pharmaceuticals Inc
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Stopped prediction by StockNews_com for Corvus Pharmaceuticals Inc
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€0.92
03.04.23
03.04.23
-
03.04.24
03.04.24
81.96%
04.04.24
04.04.24
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€0.65
26.03.23
26.03.23
-
26.03.24
26.03.24
144.58%
27.03.24
27.03.24
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€0.68
18.03.23
18.03.23
-
18.03.24
18.03.24
157.58%
19.03.24
19.03.24